null (GALDERMA GROUP N) aksje
GALD.SW
CHF164.40+0.50 (+0.31%)
Laster graf...
GALDERMA GROUP N
Market Cap
$38,563,094,528
Åpning165.10
Høy165.85
Lav162.20
Volum268.73k
P/E81.39
Markedsverdi38.56B
52-ukers høy171.90
52-ukers lav107.40
Gj.sn. volum1.15M
Utbytte0.21%
Beta-0.05
EPS2.02
Om null (GALDERMA GROUP N) aksje
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Selskapsinformasjon
Børs: Swiss (EBS)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
Zählerweg 10
6300 Zug, Switzerland
6300 Zug, Switzerland
Telefon: + 41 58 455 85 92
Nettside: https://www.galderma.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.72 - Køb
Laveste kursmål
113.59
↓ 30.9%
Gjennomsnittlig kursmål
184.04
↑ 11.9%
Median kursmål
189.93
↑ 15.5%
Høyeste kursmål
260.57
↑ 58.5%